Autori: Subramanian Janakiraman
| Naslov | Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung cancer (Article) |
| Autori | Domine Gomez Manuel Csoszi Tibor Jaal Jana Kudaba Iveta Nikolov Krassimir Radosavljevic Davorin Z Xiao Jie Horton Janet K Malik Rajesh K Subramanian Janakiraman |
| Info | INTERNATIONAL JOURNAL OF CANCER, (2021), vol. 149 br. 7, str. 1463-1472 |
| Projekat | G1 Therapeutics, Inc. |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Using an Exploratory Composite Endpoint to Evaluate the Myelopreservation Benefits of Trilaciclib in Patients with Small Cell Lung Cancer (Meeting Abstract) |
| Autori | Subramanian Janakiraman Jaal Jana Kudaba Iveta Nikolov Krassimir Radosavljevic Davorin Z Csoszi Tibor Xiao J Horton Janet K Malik RK Gomez MD |
| Info | JOURNAL OF THORACIC ONCOLOGY, (2021), vol. 16 br. 1, Suppl. S, str. S33-S33 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study (Article) |
| Autori | Hart Lowell L Ferrarotto Renata Andric Zoran G Beck Thaddeus J Subramanian Janakiraman Radosavljevic Davorin Z Zaric Bojan Hanna Wahid T Aljumaily Raid Owonikoko Taofeek K Verhoeven Didier Xiao Jie Morris Shannon R Antal Joyce M Hussein Maen A |
| Info | ADVANCES IN THERAPY, (2021), vol. 38 br. 1, str. 350-365 |
| Projekat | G1 Therapeutics, Inc. (Research Triangle Park, NC) |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
